Diabetes is Associated with Severe Adverse Events in Multidrug-Resistant Tuberculosis.

CONCLUSIONS: Our data suggest that DM does not impact second-line TB treatment outcomes, but patients with DM have a higher risk of developing serious AEs to drug-resistant TB treatment, such as nephrotoxicity and hypothyroidism.
PMID: 28089216 [PubMed - as supplied by publisher]

Source: Archivos de Bronconeumologia - January 10, 2017 Category: Respiratory Medicine Authors: Muñoz-Torrico M, Caminero-Luna J, Migliori GB, D'Ambrosio L, Carrillo-Alduenda JL, Villareal-Velarde H, Torres-Cruz A, Flores-Vergara H, Martínez-Mendoza D, García-Sancho C, Centis R, Salazar-Lezama MÁ, Pérez-Padilla R Tags: Arch Bronconeumol Source Type: research